Clinical Trial Update: Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 head-to-head trial comparing exemestane (Aromasin) and anastrozole (Arimidex) as initial hormonal therapy in postmenopausal women with advanced or rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Aromasin (exemestane)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2012-01-25